Sonic Hedgehog-Induced Histone Deacetylase Activation Is Required for Cerebellar Granule Precursor Hyperplasia in Medulloblastoma

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Lee, Seung Joon ^a   Lindsey, Stephan ^a   Graves, Bruce ^a   Yoo, Soonmoon ^a   Olson, James M ^b   Langhans, Sigrid A ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; MESSENGER RNA; SONIC HEDGEHOG PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CELL PROLIFERATION; CELL SURVIVAL; CEREBELLAR GRANULE PRECURSOR; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXTERNAL GERMINAL LAYER; GERM LAYER; GRANULE CELL; MEDULLOBLASTOMA; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIMARY CELL CULTURE; PROTEIN FUNCTION; REGULATORY MECHANISM; TUMOR GROWTH; WILD TYPE;

EID: 84881223911     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071455     Document Type: Article

References (29)

1. Altman J, Bayer SA (1997) Development of the cerebellar system: in relation to its evolution, structure, and functions. Boca Raton: CRC Press. 783 p., [716]. of plates p.
2. Komuro H, Rakic P, (1998) Distinct modes of neuronal migration in different domains of developing cerebellar cortex. J Neurosci 18: 1478-1490.
3. Wechsler-Reya RJ, Scott MP, (1999) Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22: 103-114.
4. Ingham PW, McMahon AP, (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15: 3059-3087.
5. Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, et al. (1997) Sporadic medulloblastomas contain PTCH mutations. Cancer Res 57: 842-845.
6. Ellison DW, Clifford SC, Gajjar A, Gilbertson RJ, (2003) What's new in neuro-oncology? Recent advances in medulloblastoma. Eur J Paediatr Neurol 7: 53-66.
7. Goodrich LV, Milenkovic L, Higgins KM, Scott MP, (1997) Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277: 1109-1113.
8. Hallahan AR, Pritchard JI, Hansen S, Benson M, Stoeck J, et al. (2004) The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res 64: 7794-7800.
9. Schuller U, Heine VM, Mao J, Kho AT, Dillon AK, et al. (2008) Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 14: 123-134.
10. Yang ZJ, Ellis T, Markant SL, Read TA, Kessler JD, et al. (2008) Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 14: 135-145.
11. Oliver TG, Read TA, Kessler JD, Mehmeti A, Wells JF, et al. (2005) Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development 132: 2425-2439.
12. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB, (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370: 737-749.
13. Hagelkruys A, Sawicka A, Rennmayr M, Seiser C, (2011) The biology of HDAC in cancer: the nuclear and epigenetic components. Handb Exp Pharmacol 206: 13-37.
14. Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, et al. (2010) HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin Cancer Res 16: 3240-3252.
15. Vibhakar R, Foltz G, Yoon JG, Field L, Lee H, et al. (2007) Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma. Neuro Oncol 9: 135-144.
16. Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, et al. (2008) The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. Cancer Res 68: 1768-1776.
17. Hassig CA, Symons KT, Guo X, Nguyen PM, Annable T, et al. (2008) KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo. Mol Cancer Ther 7: 1054-1065.
18. Marks BD, Fakhoury SA, Frazee WJ, Eliason HC, Riddle SM, (2011) A substrate-independent TR-FRET histone deacetylase inhibitor assay. J Biomol Screen 16: 1247-1253.
19. Sonnemann J, Kumar KS, Heesch S, Muller C, Hartwig C, et al. (2006) Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Int J Oncol 28: 755-766.
20. Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, et al. (2010) Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc. 132: 10842-10846.
21. Avila AM, Burnett BG, Taye AA, Gabanella F, Knight MA, et al. (2007) Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest 117: 659-671.
22. d'Ydewalle C, Krishnan J, Chiheb DM, Van Damme P, Irobi J, et al. (2011) HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med 17: 968-974.
23. Mentis GZ, Blivis D, Liu W, Drobac E, Crowder ME, et al. (2011) Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron 69: 453-467.
24. Gilbertson RJ, Ellison DW, (2008) The origins of medulloblastoma subtypes. Annu Rev Pathol 3: 341-365.
25. Canettieri G, Di Marcotullio L, Greco A, Coni S, Antonucci L, et al. (2010) Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation. Nat Cell Biol 12: 132-142.
26. Marino S, (2005) Medulloblastoma: developmental mechanisms out of control. Trends Mol Med 11: 17-22.
27. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, et al. (2010) Subtypes of medulloblastoma have distinct developmental origins. Nature 468: 1095-1099.
28. Spiller SE, Ditzler SH, Pullar BJ, Olson JM, (2008) Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA). J Neurooncol 87: 133-141.
29. Witt O, Deubzer HE, Milde T, Oehme I, (2009) HDAC family: What are the cancer relevant targets? Cancer Lett 277: 8-21.